Acorn Capital Advisors, LLC Puma Biotechnology, Inc. Transaction History
Acorn Capital Advisors, LLC
- $153 Billion
- Q2 2025
A detailed history of Acorn Capital Advisors, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 4,131,299 shares of PBYI stock, worth $20.1 Million. This represents 9.27% of its overall portfolio holdings.
Number of Shares
4,131,299
Previous 3,940,052
4.85%
Holding current value
$20.1 Million
Previous $11.7 Billion
21.5%
% of portfolio
9.27%
Previous 7.78%
Shares
3 transactions
Others Institutions Holding PBYI
# of Institutions
124Shares Held
33.3MCall Options Held
68.2KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA3.71MShares$18.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$17.4 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA2.01MShares$9.78 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.87MShares$9.13 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO1.34MShares$6.54 Million0.0% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $222M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...